Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation

JB Woillard; M Mourad; M Neely; A Capron; Ron van Schaik; Teun Gelder; N Lloberas; Dennis Hesselink; P Marquet; V Haufroid; L Elens

doi:10.3389/fphar.2017.00358

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation

JB Woillard
, M Mourad
, M Neely
, A Capron
, Ron van Schaik
, Teun Gelder
, N Lloberas
, Dennis Hesselink
, P Marquet
, V Haufroid
, L Elens

Research output: Contribution to journal › Article › Academic › peer-review

53 Citations (Scopus)

38 Downloads (Pure)

Original language	Undefined/Unknown
Article number	358
Journal	Frontiers in Pharmacology
Volume	8
DOIs	https://doi.org/10.3389/fphar.2017.00358
Publication status	Published - 2017

Research programs

EMC MM-01-25-01

Access to Document

10.3389/fphar.2017.00358

REPUB_100584.pdfFinal published version, 2.09 MB

http://hdl.handle.net/1765/100584

Cite this

Woillard, JB., Mourad, M., Neely, M., Capron, A., van Schaik, R., Gelder, T., Lloberas, N., Hesselink, D., Marquet, P., Haufroid, V., & Elens, L. (2017). Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation. Frontiers in Pharmacology, 8, Article 358. https://doi.org/10.3389/fphar.2017.00358

@article{565aa9fda58d47659ffaa32232f68605,

title = "Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation",

author = "JB Woillard and M Mourad and M Neely and A Capron and \{van Schaik\}, Ron and Teun Gelder and N Lloberas and Dennis Hesselink and P Marquet and V Haufroid and L Elens",

year = "2017",

doi = "10.3389/fphar.2017.00358",

language = "Undefined/Unknown",

volume = "8",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation

AU - Woillard, JB

AU - Mourad, M

AU - Neely, M

AU - Capron, A

AU - van Schaik, Ron

AU - Gelder, Teun

AU - Lloberas, N

AU - Hesselink, Dennis

AU - Marquet, P

AU - Haufroid, V

AU - Elens, L

PY - 2017

Y1 - 2017

U2 - 10.3389/fphar.2017.00358

DO - 10.3389/fphar.2017.00358

M3 - Article

C2 - 28642710

SN - 1663-9812

VL - 8

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 358

ER -